Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

April’s top news stories

Novartis has agreed to acquire anti-inflammatory group IFM Tre, a subsidiary of IFM Therapeutics, in a deal worth up to $1.57bn, and GSK has announced plans to invest $100m to support long-term vaccine manufacturing capabilities at its facility in Hamilton, Montana, US. Pharmaceutical-technology.com wraps up key headlines from April 2019.

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top